中文名 | 4-[4-[[5-氟-4-[[3-[(1-氧代-2-丙烯-1-基)氨基]苯基]氨基]-2-嘧啶基]氨基]苯氧基]-N-甲基-2-吡啶甲酰胺 |
---|---|
英文名 | 4-{4-[(4-{[3-(Acryloylamino)phenyl]amino}-5-fluoro-2-pyrimidinyl) amino]phenoxy}-N-methyl-2-pyridinecarboxamide |
英文别名 |
4-(4-(4-(3-acrylamidophenylamino)-5-fluoropyrimidin-2-ylamino)phenoxy)-N-methylpicolinamide
Coumarin,7-methoxy-3-phenyl-4-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl) 4-{4-[(4-{[3-(Acryloylamino)phenyl]amino}-5-fluoro-2-pyrimidinyl)amino]phenoxy}-N-methyl-2-pyridinecarboxamide 2-Pyridinecarboxamide, 4-[4-[[5-fluoro-4-[[3-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-2-pyrimidinyl]amino]phenoxy]-N-methyl- 2H-1-Benzopyran-2-one,7-methoxy-3-phenyl-4-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl) 7-Methoxy-3-phenyl-4-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)coumarin 4-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-7-methoxy-3-phenyl-2H-chromen-2-one CNX-774 |
描述 | CNX-774是口服活性的高效Btk抑制剂,IC50< 1 nM,能与活性位点上的Cys-481形成配体导向的共价键。 |
---|---|
相关类别 | |
参考文献 |
[2]. In Vitro Reactivity Assessment of Covalent Drugs Targeting Bruton's Tyrosine Kinase |
密度 | 1.4±0.1 g/cm3 |
---|---|
分子式 | C26H22FN7O3 |
分子量 | 499.496 |
精确质量 | 499.176819 |
PSA | 136.88000 |
LogP | 3.15 |
外观性状 | 粉末 |
折射率 | 1.690 |
储存条件 | -20℃ |
危害码 (欧洲) | N |
---|